Takeda inks discovery pact with Stanford; Jounce taps Ariad vet Cole as new CBO
⇨ Takeda’s research group in Cambridge, MA has struck a deal to work more closely with researchers at Stanford with an eye to moving more drugs through R&D. “Takeda’s alliance with Stanford demonstrates our commitment to advancing medicines as quickly and efficiently as possible – from drug discovery to development and ultimately to patients,” said Juan Harrison, vice president, head of strategic academic alliances, Takeda.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.